News for 1&1 Drillisch AG (DRI.DE)

Polo Tang from UBS retains his positive opinion on the stock with a Buy rating. The target price has been revised downwards and is now set at EUR 20.50 as compared to EUR 21.40 previously.

In a research note published by Usman Ghazi, Berenberg advises its customers to buy the stock. The target price is unchanged and still at EUR 32.

Polo Tang from UBS retains his positive opinion on the stock with a Buy rating. No major update to the target price set at EUR 22.00 compared to EUR 21.80.

UBS is positive on the stock with a Buy rating. The target price is unchanged at EUR 22.

In a research note, Barclays analyst Mathieu Robilliard has maintained his recommendation on the stock with a Neutral rating. The target price is unchanged at EUR 20.

Analyst Karsten Oblinger from DZ Bank research considers the stock attractive and recommends it with a Buy rating.

Already positive, the research from UBS and its analyst Polo Tang still consider the stock as a Buy opportunity. The target price is still set at EUR 20.70.

UBS is positive on the stock with a Buy rating.

In a research note published by Keval Khiroya, Deutsche Bank advises its customers to buy the stock. The target price remains unchanged at EUR 17.

In his latest research note, analyst Polo Tang confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price remains set at EUR 10.40.

In his latest research note, analyst Maurice Patrick confirms his positive recommendation. The broker Barclays is keeping its Buy rating. The target price has been revised upwards and is now set at... | February 16, 2021

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to extend the strong upward move seen last week. The markets are likely to continue to benefit from recent upward momentum, which has propelled the Nasdaq and S&P 500 to new record highs.

UBS's research confirms his advice and maintains his neutral opinion on the stock. The target price remains unchanged at EUR 20. | February 8, 2021

European stocks were moving higher on Monday amid optimism that a slowdown in the spread of coronavirus in different parts of the world and vaccine rollout efforts will result in a swifter global economic recovery.

In his latest research note, analyst Andrew Lee confirms his recommendation. The broker Goldman Sachs is keeping its Neutral rating. The target price continues to be set at EUR 21. | February 8, 2021

Ulrich Rathe from Jefferies retains his Neutral opinion on the stock. The target price continues to be set at EUR 20.20. | February 5, 2021